Literature DB >> 21945485

Molecular and functional heterogeneity of T regulatory cells.

Lequn Li1, Vassiliki A Boussiotis.   

Abstract

Naturally occurring CD4+ T regulatory (Treg) cells are produced during maturation in the thymus and have a mandatory role in maintaining homeostasis and immune quiescence. Development and function of Treg cells depends on the transcription factor forkhead box P3 (Foxp3), which is necessary and sufficient for Treg cell function. Currently emerging evidence indicates Treg cells display molecular and functional heterogeneity and can be categorized into naïve and effector- or memory-like cells, which can produce effector cytokines supporting the idea that Treg cells retain plasticity. The role of Treg cells that acquire these properties remains unclear and is currently under intense investigation. In this review, we summarize recent advances on the differentiation of effector- or memory-like Treg cells, the impact of the cytokine milieu on the molecular and functional heterogeneity of Treg cells, and the clinical implications of the heterogeneity and specialization of Treg cells.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21945485      PMCID: PMC3221919          DOI: 10.1016/j.clim.2011.08.011

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  80 in total

Review 1.  CD4 T cells: fates, functions, and faults.

Authors:  Jinfang Zhu; William E Paul
Journal:  Blood       Date:  2008-09-01       Impact factor: 22.113

2.  Preferential generation of follicular B helper T cells from Foxp3+ T cells in gut Peyer's patches.

Authors:  Masayuki Tsuji; Noriko Komatsu; Shimpei Kawamoto; Keiichiro Suzuki; Osami Kanagawa; Tasuku Honjo; Shohei Hori; Sidonia Fagarasan
Journal:  Science       Date:  2009-03-13       Impact factor: 47.728

3.  Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity.

Authors:  Noriko Komatsu; Maria Encarnita Mariotti-Ferrandiz; Ying Wang; Bernard Malissen; Herman Waldmann; Shohei Hori
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-27       Impact factor: 11.205

Review 4.  Establishment of the gut microbiota in Western infants.

Authors:  I Adlerberth; A E Wold
Journal:  Acta Paediatr       Date:  2009-02       Impact factor: 2.299

5.  Identification of IL-17-producing FOXP3+ regulatory T cells in humans.

Authors:  Kui Shin Voo; Yui-Hsi Wang; Fabio R Santori; Cesar Boggiano; Yi-Hong Wang; Kazuhiko Arima; Laura Bover; Shino Hanabuchi; Jahan Khalili; Ekaterina Marinova; Biao Zheng; Dan R Littman; Yong-Jun Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-09       Impact factor: 11.205

6.  Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells.

Authors:  Hans J P M Koenen; Ruben L Smeets; Paul M Vink; Esther van Rijssen; Annemieke M H Boots; Irma Joosten
Journal:  Blood       Date:  2008-07-10       Impact factor: 22.113

7.  IL-2, -7, and -15, but not thymic stromal lymphopoeitin, redundantly govern CD4+Foxp3+ regulatory T cell development.

Authors:  Kieng B Vang; Jianying Yang; Shawn A Mahmud; Matthew A Burchill; Amanda L Vegoe; Michael A Farrar
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

8.  DC activated via dectin-1 convert Treg into IL-17 producers.

Authors:  Fabiola Osorio; Salomé LeibundGut-Landmann; Matthias Lochner; Katharina Lahl; Tim Sparwasser; Gérard Eberl; Caetano Reis e Sousa
Journal:  Eur J Immunol       Date:  2008-12       Impact factor: 5.532

9.  Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses.

Authors:  Ye Zheng; Ashutosh Chaudhry; Arnold Kas; Paul deRoos; Jeong M Kim; Tin-Tin Chu; Lynn Corcoran; Piper Treuting; Ulf Klein; Alexander Y Rudensky
Journal:  Nature       Date:  2009-02-01       Impact factor: 49.962

10.  Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity.

Authors:  Xuyu Zhou; Lukas T Jeker; Brian T Fife; Shirley Zhu; Mark S Anderson; Michael T McManus; Jeffrey A Bluestone
Journal:  J Exp Med       Date:  2008-08-25       Impact factor: 14.307

View more
  12 in total

Review 1.  Once a Treg, always a Treg?

Authors:  Deepali V Sawant; Dario A A Vignali
Journal:  Immunol Rev       Date:  2014-05       Impact factor: 12.988

2.  The effect of extracorporeal photopheresis alone or in combination therapy on circulating CD4(+) Foxp3(+) CD25(-) T cells in patients with leukemic cutaneous T-cell lymphoma.

Authors:  Lisa H Shiue; Jacob Couturier; Dorothy E Lewis; Caimiao Wei; Xiao Ni; Madeleine Duvic
Journal:  Photodermatol Photoimmunol Photomed       Date:  2015-03-28       Impact factor: 3.135

3.  MUC1 vaccine for individuals with advanced adenoma of the colon: a cancer immunoprevention feasibility study.

Authors:  Takashi Kimura; John R McKolanis; Lynda A Dzubinski; Kazi Islam; Douglas M Potter; Andres M Salazar; Robert E Schoen; Olivera J Finn
Journal:  Cancer Prev Res (Phila)       Date:  2012-12-17

4.  Highly heterogeneous, activated, and short-lived regulatory T cells during chronic filarial infection.

Authors:  Simon Metenou; Yaya I Coulibaly; Daniel Sturdevant; Housseini Dolo; Abdallah A Diallo; Lamine Soumaoro; Michel E Coulibaly; Kishore Kanakabandi; Stephen F Porcella; Amy D Klion; Thomas B Nutman
Journal:  Eur J Immunol       Date:  2014-05-22       Impact factor: 5.532

Review 5.  Self-tolerance in multiple sclerosis.

Authors:  R E Gonsette
Journal:  Acta Neurol Belg       Date:  2012-03-24       Impact factor: 2.396

6.  The Expression of T Cell FOXP3 and T-Bet Is Upregulated in Severe but Not Euthyroid Hashimoto's Thyroiditis.

Authors:  Stana Tokić; Mario Štefanić; Ljubica Glavaš-Obrovac; Sonja Jaman; Eva Novosadová; Jana Petrkova; Zdenka Navratilova; Mirjana Suver Stević; Martin Petrek
Journal:  Mediators Inflamm       Date:  2016-07-05       Impact factor: 4.711

Review 7.  Transcriptional regulation and development of regulatory T cells.

Authors:  Wonyong Lee; Gap Ryol Lee
Journal:  Exp Mol Med       Date:  2018-03-09       Impact factor: 8.718

8.  Multiple unit pooled umbilical cord blood is a viable source of therapeutic regulatory T cells.

Authors:  Kate Milward; Fadi Issa; Joanna Hester; Daniel Figueroa-Tentori; Alejandro Madrigal; Kathryn J Wood
Journal:  Transplantation       Date:  2013-01-15       Impact factor: 4.939

9.  CD4(+)CD25(-)Nrp1(+) T cells synergize with rapamycin to prevent murine cardiac allorejection in immunocompetent recipients.

Authors:  Qing Yuan; Shanjuan Hong; Bingyi Shi; Jesper Kers; Zhouli Li; Xiangke Pei; Liang Xu; Xing Wei; Ming Cai
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

Review 10.  Regulation of T Cell Differentiation and Function by EZH2.

Authors:  Theodoros Karantanos; Anthos Chistofides; Kankana Barhdan; Lequn Li; Vassiliki A Boussiotis
Journal:  Front Immunol       Date:  2016-05-03       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.